insights_auto
Prečo akcie NOT stúpli 3,07%?
Preskúmať podrobnejšiechevron_right
NOT:ETR
Novartis
128,82 €
arrow_upward
+3,07%(+3,84) 1 d.
7. 10., 17:35:33 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NOT…
Otvoriť
125,92 €
Vysoká
128,82 €
Nízka
125,92 €
Trh. kap.
291,87 mld.
Priem. obj.
6,73 tis.
Objem
4,25 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Otvoriť
125,92 €
Vysoká
128,82 €
Nízka
125,92 €
Trh. kap.
291,87 mld.
Priem. obj.
6,73 tis.
Objem
4,25 tis.
Max. za 52 týž.
144,12 €
Min. za 52 týž.
104,52 €
Počet zamestnancov
75 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 2 hodinami
Is Novartis (SWX:NOVN) Undervalued After New MS Trial Data Took Center Stage?
Euronext Markets: Real-time Stock Market Data | live
·
pred 2 hodinami
AI companies run virtual drug trials, aim to improve success of human studies
AD HOC NEWS
·
pred 2 hodinami
SMI closes 0.14 percent higher as pharma shares offset yield pressure
Yahoo Finance
·
pred 5 hodinami
US FDA expands use of Novartis drug for chronic skin condition
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Informácie o subjekte Novartis
Generálny riaditeľVasant Narasimhan
Zamestnanci75,3 tis.
Dátum založenia7. 3. 1996
Hlavné sídloBazilej, Bazilej-mesto, Švajčiarsko
Odvetvie-
Webnovartis.com